Single, 14-Day, and 13-Week Repeated Dose Toxicity Studies of Daily Oral Gelidium elegans Extract Administration to Rats

Autor: Su-Jung Ryu, Jia Choi, Boo-Yong Lee, Kui-Jin Kim, Hee-Chul Chung, Hyung-Min Kim
Rok vydání: 2018
Předmět:
Male
0301 basic medicine
medicine.medical_specialty
No-observed-adverse-effect level
Dose
Urinalysis
Administration
Oral

Pharmaceutical Science
Physiology
Complex Mixtures
Article
Gee
Analytical Chemistry
lcsh:QD241-441
repeated dose toxicity
Rats
Sprague-Dawley

03 medical and health sciences
lcsh:Organic chemistry
Gelidium elegans
Gelidium amansii
polyphenol-rich dietary source
no observed adverse effect level
Drug Discovery
medicine
Animals
Physical and Theoretical Chemistry
Adverse effect
No-Observed-Adverse-Effect Level
030109 nutrition & dietetics
Dose-Response Relationship
Drug

medicine.diagnostic_test
business.industry
Body Weight
Organic Chemistry
Feeding Behavior
Organ Size
Rats
Diarrhea
030104 developmental biology
Chemistry (miscellaneous)
Rhodophyta
Toxicity
Molecular Medicine
Female
Histopathology
medicine.symptom
business
Zdroj: Molecules : A Journal of Synthetic Chemistry and Natural Product Chemistry
Molecules; Volume 23; Issue 1; Pages: 217
Molecules, Vol 23, Iss 1, p 217 (2018)
ISSN: 1420-3049
DOI: 10.3390/molecules23010217
Popis: Gelidium elegans extract (GEE) is derived from a red alga from the Asia–Pacific region, which has antioxidant, anti-adipogenic, and anti-hyperglycemic effects. However, detailed studies of the toxicology of GEE have not been performed. We evaluated the single oral dose toxicity of GEE in male and female Sprague-Dawley (CD) rats. GEE did not cause deaths or have toxic effects at dosages of 5000 mg/kg/day, although compound-colored stools and diarrhea were observed in both sexes, which lasted 5000 mg/kg. We next evaluated the repeated oral dose toxicity of GEE in CD rats over 14 days and 13 weeks. GEE did not induce any significant toxicological changes in either sex at 2000 mg/kg/day. Repeated oral dose toxicity studies showed no adverse effects, in terms of clinical signs, mortality, body mass, food consumption, ophthalmic examination, urinalysis, hematology, serum biochemistry, necropsy, organ masses, or histopathology, at dosages of 500, 1000, or 2000 mg/kg/day. The no observed adverse effect level (NOAEL) for GEE is thus likely to be >2000 mg/kg/day, and no pathology was identified in potential target organs. Therefore, this study indicates that repeated oral dosing with GEE is safe in CD rats.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje